Holen Sie sich die Stockscreener-App
1.39
27.52%
0.30
Handel nachbörslich:
1.43
0.04
+2.88%
Finanzdaten der Abvc Biopharma Inc-Aktie (ABVC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
200.00%
-0.796
|
0.796 | - | 0.00197 | 0.3893 |
Operating Expenses
|
11.94%
2.1989
|
1.9644 | 0.693 | 0.3361 | 0.339 |
| Operating Income/Loss |
156.32%
-2.9949
|
-1.1684 | -0.693 | -0.3342 | 0.0499 |
| Nonoperating Income/Loss |
589.42%
-0.8176
|
-0.1186 | -0.2512 | 0.4631 | -0.1839 |
| Income/Loss Before Equity Method Investments |
156.29%
-3.1594
|
-1.2328 | -0.8933 | - | -0.066 |
| Income/Loss From Equity Method Investments |
1,104%
-0.653
|
-0.0542 | -0.0509 | - | -0.0679 |
| Income/Loss From Continuing Operations Before Tax |
196.23%
-3.8124
|
-1.287 | -0.9442 | 0.1289 | -0.1339 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.000527 | - | - | 0.000355 |
| Income/Loss From Continuing Operations After Tax |
196.10%
-3.8124
|
-1.2875 | -0.9442 | 0.1289 | -0.1343 |
|
Net Income/Loss
|
196.10%
-3.8124
|
-1.2875 | -0.9442 | 0.1289 | -0.1343 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | -1.7863 | -10.16 | - |
| Attributable To Noncontrolling Interest |
508.31%
-0.2495
|
-0.041 | -0.1021 | -0.1004 | 0.0523 |
| Basic Average Shares |
93.37%
1.5415
|
23.26 | 14.97 | 0.5099 | 12.41 |
| Diluted Average Shares |
93.37%
1.5415
|
23.26 | 14.97 | 0.5099 | 12.41 |
| Basic Earnings Per Share |
220.00%
-0.16
|
-0.05 | -0.06 | 0.04 | -0.02 |
| Diluted Earnings Per Share |
220.00%
-0.16
|
-0.05 | -0.06 | 0.04 | -0.02 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | -1.7863 | -10.16 | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):